The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The Australian share market is expected to open flat on Thursday following a mixed session on Wall Street overnight.

Six of the S&P 500 industry sectors rose, led by utilities, while five fell after a slide in energy. The session was a reflection of mixed earnings reports from big US companies and signs that inflation remains high globally.

Tesla announced its fourth price cut in the US this year, with the electric-vehicle company lowering prices for its two top-selling models.

CEO Elon Musk said this was not the start of a price war, stating the company was lowering prices to enable affordability at scale.

It comes ahead of Tesla’s first-quarter earnings, which will shine a light on how previous cuts affected the company’s profit margins.

The news weighed heavily on Wall Street, and high-growth and tech stocks also contributed to pushing the market down following higher yields in the bond market. The yield rise was prompted by a report showing UK inflation stayed above 10 per cent for seven consecutive months.

Meanwhile, European markets were also mixed.

Oil prices dipped as the dollar rebounded, and a mixed oil inventory report raised demand concerns. WTI crude is back under the $80 level, with suggestions that it could continue to drop on strong dollar trade.

However, gold prices have risen back above US$2000 an ounce. It appears the precious metal is providing a safe haven during the next wave of earnings reports and as the debate over rate hikes continues.

More From The Market Online
The Market Online Video

Market Open: Wading through a flood of earnings updates

The ASX200 is not expected to do anything too dramatic as investors wade through a flood…

BPH Energy wraps up Q1 with $6.6M in cash but Canberra still stalling shareholders on PEP-11

BPH Energy wound up Q1 of CY2024 with $6.5M in cash, a growing hydrogen play and…

Orthocell’s Remplir shows 85% success rate in nerve repair study

Orthocell's medical device RemplirTM shows 85% success rate in latest nerve repair study, holding a promise…

Market Update: Sigh of relief after retail sales tumble

Australian retail sales fell 0.4% in March, a complete turnaround after February’s point-2 per cent rise.…